Urso L, Manco L, Filippi L. Synthetic imaging for research and education in nuclear medicine: Who's afraid of the black box?. Eur J Nucl Med Mol Imaging. 2025. Epub ahead of print. doi:10.1007/s00259-025-07214-1
Filippi L, Urso L*, Manco L, Olivieri M, Badrane I, Evangelista L. Insights into pet-based radiogenomics in oncology: an updated systematic review. Eur J Nucl Med Mol Imaging. 2025 Apr 7. doi: 10.1007/s00259-025-07262-7. Epub ahead of print. PMID: 40192792.
Urso L, Badrane I, Manco L, Castello A, Lancia F, Collavino J, Crestani A, Castellani M, Cittanti C, Bartolomei M, Giannarini G. The Role of Radiomics and Artificial Intelligence Applied to Staging PSMA PET in Assessing Prostate Cancer Aggressiveness. J Clin Med. 2025 May 9;14(10):3318. doi: 10.3390/jcm14103318. PMID: 40429314.
Esposito F, Manco L, Urso L, Adamantiadis S, Scribano G, De Marchi L, Venditti A, Postorino M, Urbano N, Gafà R, Cuneo A, Chiaravalloti A, Bartolomei M, Filippi L. 18F-FDG PET/CT Radiomics for Predicting Therapy Response in Primary Mediastinal B-Cell Lymphoma: A Bi-Centric Pilot Study. Cancers (Basel). 2025 May 30;17(11):1827. doi: 10.3390/cancers17111827. PMID: 40507310.
Manco, L, Szilagyi, KE & Urso, L. Artificial intelligence & nuclear medicine: an emerging partnership. Clin Transl Imaging (2025). https://doi.org/10.1007/s40336-025-00723-x.
Manco L, Urso L, Filippi L. One scan, many stories: deep learning for signal separation in multi-tracer PET imaging. Phys Med Biol. 2025;70(19):10.1088/1361-6560/ae02db.
Manco L, Proietti I, Scribano G, Pirisino R, Bagni O, Potenza C, Pellacani G, Filippi L. PET Radiomics Signatures and Artificial Intelligence for Decoding Immunotherapy Response in Advanced Cutaneous Squamous Cell Carcinoma. Applied Sciences. 2025; 15(12):6453. https://doi.org/10.3390/app15126453.
Urso L, Manco L, Cittanti C, Adamantiadis S, Szilagyi KE, Scribano G, Mindicini N, Carnevale A, Bartolomei M, Giganti M. 18F-FDG PET/CT radiomic analysis and artificial intelligence to predict pathological complete response after neoadjuvant chemotherapy in breast cancer patients. Radiol Med. 2025 Apr;130(4):543-554. doi: 10.1007/s11547-025-01958-4. Epub 2025 Jan 28. PMID: 39875749.
Urso L, Cittanti C, Manco L, Ortolan N, Borgia F, Malorgio A, Scribano G, Mastella E, Guidoboni M, Stefanelli A, Turra A, Bartolomei M. ML Models Built Using Clinical Parameters and Radiomic Features Extracted from 18F-Choline PET/CT for the Prediction of Biochemical Recurrence after Metastasis-Directed Therapy in Patients with Oligometastatic Prostate Cancer. Diagnostics (Basel). 2024 Jun 15;14(12):1264. doi: 10.3390/diagnostics14121264. PMID: 38928679; PMCID: PMC11202947.
Filippi, L., Urso, L., Bianconi, F., Palumbo, B., Marzola, M. C., Evangelista, L., & Schillaci, O. (2023). Radiomics and theranostics with molecular and metabolic probes in prostate cancer: toward a personalized approach. Expert review of molecular diagnostics, 23(3), 243–255. https://doi.org/10.1080/14737159.2023.2192351.
Evangelista L, Fiz F, Laudicella R, Bianconi F, Castello A, Guglielmo P, Liberini V, Manco L, Frantellizzi V, Giordano A, Urso L, Panareo S, Palumbo B, Filippi L. PET Radiomics and Response to Immunotherapy in Lung Cancer: A Systematic Review of the Literature. Cancers (Basel). 2023 Jun 20;15(12):3258. doi: 10.3390/cancers15123258. PMID: 37370869; PMCID: PMC10296704.
Urso, L., Manco, L., Castello, A., Evangelista, L., Guidi, G., Castellani, M., Florimonte, L., Cittanti, C., Turra, A., & Panareo, S. (2022). PET-Derived Radiomics and Artificial Intelligence in Breast Cancer: A Systematic Review. International Journal of Molecular Sciences, 23(21), 13409. https://doi.org/10.3390/ijms232113409.